| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.6M | -70.1% |
| Cost of Revenue | $4.3M | -71.6% |
| Gross Profit | $353K | -20.9% |
| R&D Expense | $0 | — |
| SG&A Expense | $2.3M | -42.3% |
| Operating Income | -$2.0M | +48.0% |
| Pre-tax Income | -$1.8M | +47.5% |
| Income Tax | $1K | -99.7% |
| Net Income | -$1.8M | +52.9% |
| EPS (Basic) | -$0.67 | +64.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $970K | +19.5% |
| Accounts Receivable | $545K | -66.2% |
| Current Assets | $7.6M | -17.6% |
| Total Assets | $9.7M | -0.1% |
| Current Liabilities | $5.1M | -13.2% |
| Total Liabilities | $5.3M | -11.6% |
| Stockholders' Equity | $4.3M | +18.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$929K | +54.9% |
| Capital Expenditures | $65K | +2066.7% |
| Investing Cash Flow | -$144K | -116.1% |
| Financing Cash Flow | $1.2M | +7.7% |
| Free Cash Flow | -$994K | +51.8% |